Institutional investors purchased a net $43.0 thousand shares of NVO during the quarter ended March 2015. This may signal that the smart money is gaining interest in this company as the 9.72% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Major industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY INVESTMENTS CANADA ULC Bought 16.1 Thousand shares of Novo Nordisk
MADRONA FUNDS LLC Bought 625.00 shares of Novo Nordisk
IMPULSORA DE FONDOS BANAMEX SA D... Sold 95.00 shares of Novo Nordisk